Omnicell, Inc. (OMCL)

From the record

Omnicell, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Omnicell, Inc.'s 10 filed years say what it did: revenue went from $696 million in fiscal 2016 to $1.2 billion in fiscal 2025, up 6.1% a year; it rose in 6 of 9 years; the deepest fall was 14% from fiscal 2022 to fiscal 2024; net income was positive in 9 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Omnicell, Inc.'s diluted share count grew about 0.3% a year, and dividends and buybacks returned about 16% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 11 sales (9 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Omnicell, Inc. earned about 0 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 25 cents per dollar of everything the company owns. Leverage: it owed about 38 cents per dollar of assets, and net share issuance: its share count grew 0.2% over the year (the filed statements).

From the record

Omnicell, Inc.'s standing among 7 graded names in its industry family: revenue of $1.2 billion in fiscal 2025 ranks in the top 50% by size; a net margin of 0.2% ranks in the bottom 36%; revenue growth of -2.9% a year over the last 3 filed years ranks in the top 50% (its annual reports).

From the record

Omnicell, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Lipps, Randall A (CHAIRMAN, CEO, as filed), filing under that title since 2006-02-07, 20.8 years (top 8% of its family); the 14 officers and directors filing in the last fifteen months have been on the record a median of 4.9 years (bottom 42%); 12 officer or director changes were reported on Form 8-K since 2023-11-13, against the 14 people in charge now (bottom 25%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Omnicell, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $197 million against no long-term debt tagged leaves 10% of its assets as net cash, top 50% of its family; cash from operations less capital spending is 7.3% of revenue (top 36%); a gross margin of 42.5% (top 50%); research spending of 7.5% of revenue (bottom 36%) (its annual report).

From the record

Omnicell, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -2.9% a year over the last three filed years against 6.1% over all 10, slowing (bottom 36% of its family); the newest year grew 6.5% (bottom 21%); research spending grew -5.5% a year (bottom 21%); capital spending grew -5.3% a year (top 36%) (its annual reports). Omnicell, Inc. reported 4 product lines in fiscal 2025: Connected Devices Software Licenses and Other at $565 million (48%), Technical Services at $260 million (22%), Saa S and Expert Services at $259 million (22%), and 1 more; 4 of 4 grew against the year before (its annual report).

From the record

Omnicell, Inc.'s newest year against its own record: revenue of $1.2 billion in fiscal 2025 came in 15% above the $1.0 billion its prior three years' pace pointed to (top 50% of its family); net income of $2 million against a prior three-year average of $731 thousand (top 7%); a net margin of 0.2% against -0.1% before (bottom 36%) (its annual reports).